z-logo
open-access-imgOpen Access
Misleading Glycated Hemoglobin Results in a Patient with Hemoglobin SC Disease
Author(s) -
Yihong Wang,
Bruce Beckwith,
Christopher Smith,
Gary L. Horowitz
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2006.082917
Subject(s) - glycated hemoglobin , hemoglobin , hemoglobin s , medicine , disease , diabetes mellitus , endocrinology , type 2 diabetes , sickle cell anemia
We encountered a 62-year-old man with hemoglobin (Hb) SC disease. Diabetes mellitus had been previously diagnosed in this patient on the basis of 2 increased fasting glucose values. During an 8-year period, his glycated Hb (GHb) was measured by 3 different methods (Table 1⇓ ), each of which was affected differently by his Hb variants. The GHb results depended more on the method used than on the patient’s mean blood glucose.View this table: Table 1. HbA1c and related measurements over time.The patient’s GHb was measured initially (April 1997) by use of the Roche Hitachi Tina-quant immunoassay. In 2003–2004, we used the Tosoh 2.2 Plus, an assay based on HPLC, which produced chromatograms that were flagged as invalid, so we sent the patient’s samples to a commercial laboratory, which used the Roche Integra …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom